Milan - Delayed Quote EUR
Bristol-Myers Squibb Company (1BMY.MI)
41.15
-0.38
(-0.92%)
As of 12:42:13 PM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 15 | 25 | 26 |
| Avg. Estimate | 11.32B | 11.64B | 46.19B | 42.98B |
| Low Estimate | 11.11B | 11.49B | 45.62B | 40.92B |
| High Estimate | 11.57B | 11.76B | 46.63B | 44.67B |
| Year Ago Sales | 12.2B | 11.89B | 48.3B | 46.19B |
| Sales Growth (year/est) | -7.24% | -2.12% | -4.37% | -6.95% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 1BMY.MI | -- | -- | -- | -- |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Neutral to Neutral | 4/23/2025 |
| Maintains | Jefferies: Buy to Buy | 4/23/2025 |
| Initiated | Piper Sandler: Overweight | 4/22/2025 |
| Maintains | UBS: Neutral to Neutral | 4/11/2025 |
| Downgrade | Goldman Sachs: Buy to Neutral | 4/8/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 2/7/2025 |
Related Tickers
LLY.MU Eli Lilly and Co
639.40
-3.15%
1SAN.MI Sanofi
87.85
-5.87%
VIRP.PA Virbac SA
304.15
-0.60%
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
51.35
-1.53%
RHHBY Roche Holding AG
38.37
+0.26%
BIIB Biogen Inc.
118.17
-0.19%
AZN AstraZeneca PLC
67.57
+0.40%
AMGN Amgen Inc.
265.86
-2.28%
ABBV AbbVie Inc.
184.60
-0.53%
GILD Gilead Sciences, Inc.
96.91
-1.27%